# Bilastine Updosing in Chronic Spontaneous Urticaria

> **NCT02213367** · PHASE3 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 30 (actual)

## Conditions studied

- Chronic Urticaria

## Interventions

- **DRUG:** Bilastine
- **DRUG:** Bilastine
- **DRUG:** Bilastin

## Key facts

- **NCT ID:** NCT02213367
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02213367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02213367, "Bilastine Updosing in Chronic Spontaneous Urticaria". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02213367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*